So what novel therapies for FH are coming down the road and might be available for use in the near future in the management of patients with FH? The 3 most promising at the current time are ApoB antisense inhibitors, microsomal triglyceride transfer protein (MTP) inhibitors, and PCSK9 inhibitors.